|
Volumn 10, Issue 8, 2004, Pages 778-780
|
Redistricting the retroviral restriction factors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CAPSID PROTEIN;
GENE PRODUCT;
REF1 PROTEIN;
TRIM1 PROTEIN;
TRIM19 PROTEIN;
TRIPARTITE MOTIF PROTEIN 5;
UNCLASSIFIED DRUG;
VIRUS PROTEIN;
ANTIVIRAL ACTIVITY;
CELL CULTURE;
CERCOPITHECIDAE;
FV1 B GENE;
FV1 GENE;
FV1 N GENE;
GENE;
GENETIC VARIABILITY;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 2;
LIFE CYCLE;
NONHUMAN;
PRIMATE;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
RETROVIRUS;
REVERSE TRANSCRIPTION;
RHESUS MONKEY;
SHORT SURVEY;
SPECIES DIFFERENCE;
VIRUS INHIBITION;
VIRUS REPLICATION;
VIRUS STRAIN;
ANIMALS;
ANTIVIRAL AGENTS;
CERCOPITHECUS AETHIOPS;
CYTOPLASM;
HIV;
HUMANS;
RETROVIRIDAE;
SPECIES SPECIFICITY;
VIRUS REPLICATION;
CERCOPITHECIDAE;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 2;
MACACA MULATTA;
PRIMATES;
RNA VIRUSES;
UNIDENTIFIED RETROVIRUS;
|
EID: 4043082010
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0804-778 Document Type: Short Survey |
Times cited : (5)
|
References (15)
|